{"api":"v1","generated_at":"2026-10-02T17:27:28.354Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-step-by-step-61ee5d","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-step-by-step-61ee5d/at/2026-10-02T12-31Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-02T12:31:46.748Z","snapshot_stamp":"2026-10-02T12-31Z","endpoint":{"slug":"api-magentlab-com-api-calc-step-by-step-61ee5d","canonical_url":"https://api.magentlab.com/api/calc/step_by_step","resource":"https://api.magentlab.com/api/calc/step_by_step","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Gomez 2016 Step-by-Step for febrile infants 90 days and younger (derivation Mintegi 2014). High if ill-appearing, age 21 days or younger, leukocyturia, or PCT >=0.5 ng/mL; else intermediate if CRP >20 mg/L or ANC >10000/uL; else low. Returns risk, low_risk, high_risk, and intermediate_risk. magent does not examine the infant or assay UA, PCT, CRP, or ANC. Not Rochester, Boston, Philadelphia, or PECARN febrile. Not a medical device and not a discharge, admission, LP, or antibiotic order.","service_name":"magent","declared_category":null,"declared_tags":["step-by-step","febrile-infant","emergency","ibi","calculator"],"route_template":null,"registry_updated":"2026-09-28T14:36:24.310Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc step by step","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-02T12:31:46.748Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-02T12:31:46.748Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T14:36:24.182Z"},"validation":{"latest":{"observed_at":"2026-10-02T14:51:17.653Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-02"},"uptime":[{"days":7,"observed":6,"passed":6,"ratio":1},{"days":30,"observed":6,"passed":6,"ratio":1},{"days":90,"observed":6,"passed":6,"ratio":1}],"history_90d":[{"observed_at":"2026-10-02T14:51:17.653Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T07:46:01.606Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T07:04:55.035Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:22:21.069Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:57:00.318Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:42:56.752Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["step-by-step","febrile-infant","emergency","ibi","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/step_by_step","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T14:36:24.182Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/step_by_step","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"age_days":47,"crp_mg_l":5,"pct_ng_ml":0.2,"anc_per_ul":4000,"leukocyturia":false,"well_appearing":true},{"age_days":47,"crp_mg_l":5,"pct_ng_ml":0.2,"anc_per_ul":4000,"leukocyturia":false,"well_appearing":true}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/step_by_step","count":2,"items":[{"risk":"low","formula":"step_by_step","age_days":47,"citation":{"id":"gomez-2016","doi":"10.1542/peds.2015-4381","pmid":"27382134","title":"Validation of the \"Step-by-Step\" Approach in the Management of Young Febrile Infants","source":"Pediatrics. 2016;138(2):e20154381","authors":"Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L"},"criteria":[{"met":true,"factor":"well_appearing"},{"met":true,"value":47,"factor":"age_gt_21"},{"met":true,"factor":"no_leukocyturia"},{"met":true,"value":0.2,"factor":"pct_lt_0_5"},{"met":true,"value":5,"factor":"crp_le_20"},{"met":true,"value":4000,"factor":"anc_le_10000"}],"crp_mg_l":5,"low_risk":true,"high_risk":false,"pct_ng_ml":0.2,"anc_per_ul":4000,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","intermediate_risk":false,"formula_expression":"risk = high if not well_appearing or age_days <= 21 or leukocyturia or pct_ng_ml >= 0.5; else intermediate if crp_mg_l > 20 or anc_per_ul > 10000; else low; low_risk iff well_appearing and age_gt_21 and no_leukocyturia and pct_lt_0_5 and crp_le_20 and anc_le_10000 (Gomez 2016 Step-by-Step; derivation Mintegi 2014)"},{"risk":"low","formula":"step_by_step","age_days":47,"citation":{"id":"gomez-2016","doi":"10.1542/peds.2015-4381","pmid":"27382134","title":"Validation of the \"Step-by-Step\" Approach in the Management of Young Febrile Infants","source":"Pediatrics. 2016;138(2):e20154381","authors":"Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L"},"criteria":[{"met":true,"factor":"well_appearing"},{"met":true,"value":47,"factor":"age_gt_21"},{"met":true,"factor":"no_leukocyturia"},{"met":true,"value":0.2,"factor":"pct_lt_0_5"},{"met":true,"value":5,"factor":"crp_le_20"},{"met":true,"value":4000,"factor":"anc_le_10000"}],"crp_mg_l":5,"low_risk":true,"high_risk":false,"pct_ng_ml":0.2,"anc_per_ul":4000,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","intermediate_risk":false,"formula_expression":"risk = high if not well_appearing or age_days <= 21 or leukocyturia or pct_ng_ml >= 0.5; else intermediate if crp_mg_l > 20 or anc_per_ul > 10000; else low; low_risk iff well_appearing and age_gt_21 and no_leukocyturia and pct_lt_0_5 and crp_le_20 and anc_le_10000 (Gomez 2016 Step-by-Step; derivation Mintegi 2014)"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["age_days","well_appearing","leukocyturia","pct_ng_ml","crp_mg_l","anc_per_ul"],"properties":{"age_days":{"type":"integer","description":"Chronological age in days (integer 0-90). Gomez 2016 studied febrile infants 90 days and younger. Age 21 days or younger is high-risk. Age 22 can be low-risk when remaining low-risk criteria hold."},"crp_mg_l":{"type":"number","description":"C-reactive protein in mg/L. Range 0-500. Intermediate (when not already high) if greater than 20 mg/L (20 is not intermediate). magent does not assay CRP."},"pct_ng_ml":{"type":"number","description":"Serum procalcitonin in ng/mL. Range 0.01-100. High-risk if 0.5 ng/mL or greater (0.5 is high). Low-risk requires less than 0.5. magent does not assay procalcitonin."},"anc_per_ul":{"type":"number","description":"Absolute neutrophil count in cells/µL. Range 0-100000. Intermediate (when not already high) if greater than 10000/µL (10000 is not intermediate). magent does not assay ANC."},"leukocyturia":{"type":"boolean","description":"Caller-assigned leukocyturia (urine dipstick / UA leukocytes) as used in Gomez 2016. true means leukocytes are present and is high-risk. true or false. magent does not assay UA."},"well_appearing":{"type":"boolean","description":"Caller-assigned well-appearing as used in Gomez 2016. true or false. Ill-appearing (well_appearing=false) is high-risk. magent does not examine the infant."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Gomez 2016 Step-by-Step for febrile infants 90 days and younger (derivation Mintegi 2014). High if ill-appearing, age 21 days or younger, leukocyturia, or PCT >=0.5 ng/mL; else intermediate if CRP >20 mg/L or ANC >10000/uL; else low. Returns risk, low_risk, high_risk, and intermediate_risk. magent does not examine the infant or assay UA, PCT, CRP, or ANC. Not Rochester, Boston, Philadelphia, or PECARN febrile. Not a medical device and not a discharge, admission, LP, or antibiotic order.","lastUpdated":"2026-09-28T14:36:24.31Z","serviceName":"magent","x402Version":2}]}}